AIDS Treatment News logo      

February 23, 2010

Aidsmap.com on CROI (the Retroviruses conference)

For excellent reports on the 17th Conference on Retroviruses and Opportunistic Infections (CROI), San Francisco Feb. 16-19, 2010, see http://www.aidsmap.com/cms1374931.aspx.

Topics reported include:
Successful hepatitis C treatment reduces HIV disease progression and non-liver-related mortality 
Antiretroviral drugs have variable effects on bones and fat, lipoatrophy uncommon with modern regimens
HIV treatment may prevent at least nine out of ten transmissions
Vitamin D deficiency extremely common among HIV-positive patients in diverse regions
Maraviroc showing tantalising promise as microbicide in preclinical studies
Smoking cessation lowers cardiovascular risk in D:A:D cohort
Immune restoration in DART study: late start means low CD4 count for years
New CCR5 antagonist TBR-652 shows good antiviral activity in early study
Elvitegravir 'Quad' pill performs well, new booster cobicistat works as well as ritonavir
Risk factors for lung cancer in people with HIV: smoking vastly outweighs HIV
Goosby warns of need for long-term funding commitment for AIDS, says financial trades tax is 'interesting'
and many more.
 
 
 
 
 
 
 
 
 
Posted by John S. James at 12:40 AM

0 comments:

Post a Comment

Newer Post Older Post Home
Subscribe to: Post Comments (Atom)

Click line below for recent tweets:

Tweets by @cure4
AIDS Search Engine, by John S. James


Sites searched (blogroll)

Global visitors starting 2011-08-12:
Medical & Reference
Medical Dictionary
   (with audio pronounciation)
Journal articles
   (AIDS, 2011, free full text)
HIV Clinical Trials
   (US, enrolling)

Subscribe to this blog

Subscribe in a reader

Subscribe by email

Enter your email address:

Delivered by FeedBurner

AIDS Treatment News Archive (our old site)

Blog archive

  • ►  2021 (1)
    • ►  02 (1)
  • ►  2014 (1)
    • ►  10 (1)
  • ►  2013 (1)
    • ►  03 (1)
  • ►  2012 (5)
    • ►  12 (1)
    • ►  07 (2)
    • ►  04 (1)
    • ►  02 (1)
  • ►  2011 (84)
    • ►  12 (1)
    • ►  08 (1)
    • ►  04 (1)
    • ►  03 (1)
    • ►  02 (36)
    • ►  01 (44)
  • ▼  2010 (471)
    • ►  12 (31)
    • ►  11 (43)
    • ►  10 (56)
    • ►  09 (53)
    • ►  08 (54)
    • ►  07 (87)
    • ►  06 (26)
    • ►  05 (23)
    • ►  04 (14)
    • ►  03 (29)
    • ▼  02 (15)
      • Hep C Treatment Might Also Guard Against HIV Disea...
      • H1N1 Meets HIV
      • Measurement of Naive CD4 Cells Reliably Predicts P...
      • Gardasil highly effective at preventing pre-cancer...
      • FDA warns that saquinavir/ritonavir can cause hear...
      • Aidsmap.com on CROI (the Retroviruses conference)
      • Highlights from the 2010 Conference on Retroviral ...
      • Retroviruses conference events -- BEFORE they happen
      • Stay Connected to Research and Events at the 2010 ...
      • SWITCHMRK — Raltegravir Is Not for Everyone!
      • Less resistance with FTC than 3TC when combined wi...
      • Rights of vulnerable people and the future of HIV/...
      • Tesamorelin safe and effective for fat accumulatio...
      • FDA revises ddI product label to warn of serious l...
      • Compound found that targets wide range of viruses
    • ►  01 (40)
  • ►  2009 (354)
    • ►  12 (46)
    • ►  11 (34)
    • ►  10 (40)
    • ►  09 (66)
    • ►  08 (49)
    • ►  07 (75)
    • ►  06 (44)
Simple theme. Powered by Blogger.